CNS Drugs

Anaesthetic-Related Neuroprotection: Intravenous or Inhalational Agents?
pp. 893-907(15)
Authors: Schifilliti, Daniela; Grasso, Giovanni; Conti, Alfredo; Fodale, Vincenzo

The Pharmacoeconomics of Cognitive Enhancers in Moderate to Severe Alzheimer's Disease
pp. 909-927(19)
Authors: Cappell, Jaclyn; Herrmann, Nathan; Cornish, Stephen; Lanctôt, Krista L.

Innovative Delivery Systems for Migraine: The Clinical Utility of a Transdermal Patch for the Acute Treatment of Migraine
pp. 929-940(12)
Authors: Rapoport, Alan M.; Freitag, Fred; Pearlman, Starr H.

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson's Disease
pp. 941-968(28)
Authors: Perez-Lloret, Santiago; Rascol, Olivier

Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Multiple Sclerosis: A Retrospective, Multicentre Case Series
pp. 969-976(8)
Authors: Fragoso, Yára D.; Finkelsztejn, Alessandro; Kaimen-Maciel, Damacio R.; Grzesiuk, Anderson K.; Gallina, Andre S.; Lopes, Josiane; Morales, Nivea M.O.; Alves-Leon, Soniza V.; de Almeida, Sandra M.G.

Ocular Adverse Effects of Common Psychotropic Agents: A Review
pp. 977-977(1)
Author: Razeghinejad, M. Reza

The Authors' Reply
pp. 977-978(2)
Authors: Richa, Sami; Yazbek, Jean-Claude